CAMBRIDGE, Mass.--(BUSINESS WIRE)--Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the FDA has approved IMKELDI (imatinib) oral solution, the first ...
Epstein-Barr Virus–Induced Secondary High-Grade Transformation of Sjögren's Syndrome–Related Mucosa-Associated Lymphoid Tissue Lymphoma ...
Chronic lymphocytic leukemia highlights from ASH 2025 include a robust array of practice-changing phase 3 trials and data on therapies in development, as discussed by Dr Jennifer Woyach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback